Clinicopathological predictors of long-term benefit in breast cancer treated with neoadjuvant chemotherapy

doi:10.5306/wjco.v9.i2.33

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8592)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

481

WORD

244

HTML

3236

Figures (1-2)

165

Tables (1-3)

173

Sum=4299

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

810

Download

952

Sum=1762

Publishing Process of This Article

Item

Count

Browse

1002

Download

1529

Sum=2531

Apr 10, 2018 (publication date) through May 4, 2024

Times Cited of This Article

Times Cited (20)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Clin Oncol. Apr 10, 2018; 9(2): 33-41
Published online Apr 10, 2018. doi: 10.5306/wjco.v9.i2.33

Full Size Figure Download Figure

Figure 2 Overall survival regarding pathological complete response for Luminal A (A), Luminal B (B), HER2-enriched (C) and triple negative group (D).

Citation: Galvez M, Castaneda CA, Sanchez J, Castillo M, Rebaza LP, Calderon G, Cruz MDL, Cotrina JM, Abugattas J, Dunstan J, Guerra H, Mejia O, Gomez HL. Clinicopathological predictors of long-term benefit in breast cancer treated with neoadjuvant chemotherapy. World J Clin Oncol 2018; 9(2): 33-41
URL: https://www.wjgnet.com/2218-4333/full/v9/i2/33.htm
DOI: https://dx.doi.org/10.5306/wjco.v9.i2.33